Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: Correction to: Homologous targeting nanoparticles for enhanced PDT against osteosarcoma HOS cells and the related molecular mechanisms

Fig. 2

Biosafety of the MH-PLGA-IR780 NPs. A Relative viability (%) of HOS cells after coincubation with a wide range of NPs concentrations. B Relative viability (%) of HOS cells after coincubation with MH-PLGA-IR780 NPs (PLGA: 0.2 mg/mL) at prolonged time points. (The data are presented as the mean ± SD). C, D Blood indexes (routine blood and biochemistry) and H&E staining of the main organs (heart, liver, spleen, lung and kidney) of BALB/c nude mice were collected at 0, 1, 7, 14, and 28 days after post injection of MH-PLGA-IR780 NPs (n = 5). The scale bars represent 100 µm

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us